Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 11 - 20 of about 127   

Articles published

GSK 1,637.50 +4.00 (0.24%)
price chart
Medecins Sans Frontieres Happy with GlaxoSmithKline PLC (ADR) (GSK) Price ...
Numerous complaints by medical charity Medecins Sans Frontieres over the cost of pneumococcal vaccine given to refugees by GlaxoSmithKline PLC (ADR) (NYSE:GSK) have yielded fruit. The British drugmaker says that it will lower the price of Synflorix, ...
GlaxoSmithKline plc 10.5% Potential Upside Indicated by Goldman Sachs
GlaxoSmithKline plc using EPIC/TICKER code LON:GSK has had its stock rating noted as 'Reiterates' with the recommendation being set at 'BUY' today by analysts at Goldman Sachs.
GlaxoSmithKline PLC's (GSK) "Buy" Rating Reiterated at Bank of ...  The Cerbat Gem
The Statistics Don't Lie: GlaxoSmithKline plc (NYSE:GSK) Earnings Preview  The Voice Registrar
GlaxoSmithKline's shingles vaccine lasts four years in elderly patients
Pharma giant GlaxoSmithKline PLC (LON:GSK) has shown that its shingles vaccine Shingrix remained effective in elderly patients after four years.
Form 6-K GLAXOSMITHKLINE PLC For: Sep 15  StreetInsider.com
Glaxo's Shingles Shot Maintains Efficacy for Four Years in Study  Bloomberg
GlaxoSmithKline plc 24.4% Potential Upside Indicated by HSBC
GlaxoSmithKline plc with EPIC/TICKER LON:GSK had its stock rating noted as 'Reiterates' with the recommendation being set at 'BUY' today by analysts at HSBC.
JPMorgan Chase & Co. Reiterates Neutral Rating for GlaxoSmithKline PLC (GSK)  The Cerbat Gem
Beaufort Securities Reiterates "Buy" Rating for GlaxoSmithKline ...  Community Financial News
GlaxoSmithKline plc 18.7% Potential Upside Indicated by Liberum Capital
GlaxoSmithKline plc using EPIC/TICKER code LON:GSK had its stock rating noted as 'Resumes' with the recommendation being set at 'BUY' today by analysts at Liberum Capital.
GlaxoSmithKline plc (GSK) Downgraded by Societe Generale to "Sell"  The Cerbat Gem
GlaxoSmithKline plc (GSK) Price Target Lowered to GBX 1900 at Jefferies Group  BBNS
Glaxo names Emma Walmsley as new CEO to succeed Andrew Witty
GlaxoSmithKline Plc promoted Emma Walmsley to be its new chief executive officer and succeed Andrew Witty when he retires , singling out the UK ' s largest drugmaker as the only major global pharmaceutical company led by a woman .
Will GlaxoSmithKline plc (ADR) (GSK) Exhibit Growth After Patent Cliff?
Majority of the investors are skeptical about the future prospects of GlaxoSmithKline plc (ADR) (NYSE:GSK) due to its performance in 2015, as it was hit hard by the patent cliff.
GlaxosmithKline hails double drug successes
Drug giant GlaxoSmithKline PLC (LON:GSK) reported a double whammy of drug successes on Monday. GSK and its US partner Innoviva, Inc. (NASDAQ:INVA) said the results from its pioneering Salford Lung Study (SLS) have been published in the New ...
GlaxoSmithKline Plc (NYSE:GSK) Posts Positive Results On COPD Salford Lung Study  Market Exclusive
GlaxoSmithKline plc 12.3% Potential Upside Indicated by Deutsche Bank
GlaxoSmithKline plc using EPIC/TICKER code LON:GSK had its stock rating noted as 'Retains' with the recommendation being set at 'HOLD' this morning by analysts at Deutsche Bank.
GlaxoSmithKline plc's (GSK) "Hold" Rating Reaffirmed at ...  Community Financial News
GlaxoSmithKline plc (NYSE:GSK) (GSK), Johnson & Johnson (NYSE:JNJ) Submit ...
GlaxoSmithKline plc (NYSE:GSK) (GSK) revealed on Monday that it has completed the Marketing Authorization Application (MAA) submission to the European Medicines Agency (EMA), seeking approval of the subcutaneous formulation of human ...